Sævik measures corticosteroid levels in people with Addison’s disease to challenge the pervasive idea that these patients lose all adrenal cortex function as their disease progresses.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?